Arkema SA (AKE) - Net Assets
Based on the latest financial reports, Arkema SA (AKE) has net assets worth €6.34 Billion EUR (≈ $7.41 Billion USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€14.22 Billion ≈ $16.63 Billion USD) and total liabilities (€7.88 Billion ≈ $9.21 Billion USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check tangible net worth ratio of Arkema SA to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €6.34 Billion |
| % of Total Assets | 44.59% |
| Annual Growth Rate | 6.13% |
| 5-Year Change | -1.86% |
| 10-Year Change | 46.67% |
| Growth Volatility | 132.03 |
Arkema SA - Net Assets Trend (2001–2025)
This chart illustrates how Arkema SA's net assets have evolved over time, based on quarterly financial data. See AKE days of operational coverage to measure how many days the company can operate on defensive assets alone.
Annual Net Assets for Arkema SA (2001–2025)
The table below shows the annual net assets of Arkema SA from 2001 to 2025. For live valuation and market cap data, see AKE market cap.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | €6.23 Billion ≈ $7.29 Billion |
-19.70% |
| 2024-12-31 | €7.76 Billion ≈ $9.07 Billion |
+4.10% |
| 2023-12-31 | €7.46 Billion ≈ $8.72 Billion |
+1.58% |
| 2022-12-31 | €7.34 Billion ≈ $8.58 Billion |
+15.57% |
| 2021-12-31 | €6.35 Billion ≈ $7.42 Billion |
+21.30% |
| 2020-12-31 | €5.24 Billion ≈ $6.12 Billion |
-1.67% |
| 2019-12-31 | €5.32 Billion ≈ $6.22 Billion |
+5.89% |
| 2018-12-31 | €5.03 Billion ≈ $5.88 Billion |
+12.38% |
| 2017-12-31 | €4.47 Billion ≈ $5.23 Billion |
+5.30% |
| 2016-12-31 | €4.25 Billion ≈ $4.97 Billion |
+7.60% |
| 2015-12-31 | €3.95 Billion ≈ $4.62 Billion |
+10.52% |
| 2014-12-31 | €3.57 Billion ≈ $4.18 Billion |
+52.11% |
| 2013-12-31 | €2.35 Billion ≈ $2.75 Billion |
+1.64% |
| 2012-12-31 | €2.31 Billion ≈ $2.70 Billion |
+4.24% |
| 2011-12-31 | €2.22 Billion ≈ $2.59 Billion |
-1.03% |
| 2010-12-31 | €2.24 Billion ≈ $2.62 Billion |
+23.55% |
| 2009-12-31 | €1.81 Billion ≈ $2.12 Billion |
-10.16% |
| 2008-12-31 | €2.02 Billion ≈ $2.36 Billion |
+4.29% |
| 2007-12-31 | €1.94 Billion ≈ $2.26 Billion |
-0.15% |
| 2006-12-31 | €1.94 Billion ≈ $2.27 Billion |
+32.47% |
| 2005-12-31 | €1.46 Billion ≈ $1.71 Billion |
-14.79% |
| 2004-12-31 | €1.72 Billion ≈ $2.01 Billion |
+652.74% |
| 2003-12-31 | €228.10 Million ≈ $266.67 Million |
-80.92% |
| 2002-12-31 | €1.20 Billion ≈ $1.40 Billion |
-20.05% |
| 2001-12-31 | €1.50 Billion ≈ $1.75 Billion |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Arkema SA's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 437500000000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €4.38 Billion | 72.40% |
| Common Stock | €761.00 Million | 12.59% |
| Other Comprehensive Income | €-180.00 Million | -2.98% |
| Other Components | €1.09 Billion | 17.99% |
| Total Equity | €6.04 Billion | 100.00% |
Arkema SA Competitors by Market Cap
The table below lists competitors of Arkema SA ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Reynolds Consumer Products Inc
NASDAQ:REYN
|
$4.94 Billion |
|
Choice Hotels International Inc
NYSE:CHH
|
$4.94 Billion |
|
ChampionX Corporation
NASDAQ:CHX
|
$4.94 Billion |
|
Acter Co Ltd
TWO:5536
|
$4.95 Billion |
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
$4.93 Billion |
|
Sonoco Products Company
NYSE:SON
|
$4.93 Billion |
|
Macy’s Inc
NYSE:M
|
$4.93 Billion |
|
Mirvac Group
AU:MGR
|
$4.93 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Arkema SA's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 7,526,000,000 to 6,043,000,000, a change of -1,483,000,000 (-19.7%).
- Net income of 63,000,000 contributed positively to equity growth.
- Dividend payments of 272,000,000 reduced retained earnings.
- Share repurchases of 33,000,000 reduced equity.
- Other comprehensive income decreased equity by 1,228,000,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €63.00 Million | +1.04% |
| Dividends Paid | €272.00 Million | -4.5% |
| Share Repurchases | €33.00 Million | -0.55% |
| Other Comprehensive Income | €-1.23 Billion | -20.32% |
| Other Changes | €-13.00 Million | -0.22% |
| Total Change | €- | -19.71% |
Book Value vs Market Value Analysis
This analysis compares Arkema SA's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.73x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 2.17x to 0.73x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2004-12-31 | €26.75 | €58.10 | x |
| 2005-12-31 | €23.04 | €58.10 | x |
| 2006-12-31 | €29.62 | €58.10 | x |
| 2007-12-31 | €30.41 | €58.10 | x |
| 2008-12-31 | €31.87 | €58.10 | x |
| 2009-12-31 | €28.60 | €58.10 | x |
| 2010-12-31 | €35.02 | €58.10 | x |
| 2011-12-31 | €33.94 | €58.10 | x |
| 2012-12-31 | €34.98 | €58.10 | x |
| 2013-12-31 | €35.18 | €58.10 | x |
| 2014-12-31 | €53.08 | €58.10 | x |
| 2015-12-31 | €52.73 | €58.10 | x |
| 2016-12-31 | €55.73 | €58.10 | x |
| 2017-12-31 | €58.41 | €58.10 | x |
| 2018-12-31 | €65.19 | €58.10 | x |
| 2019-12-31 | €68.82 | €58.10 | x |
| 2020-12-31 | €67.63 | €58.10 | x |
| 2021-12-31 | €83.09 | €58.10 | x |
| 2022-12-31 | €98.09 | €58.10 | x |
| 2023-12-31 | €95.98 | €58.10 | x |
| 2024-12-31 | €100.07 | €58.10 | x |
| 2025-12-31 | €79.55 | €58.10 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Arkema SA utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 1.04%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.69%
- • Asset Turnover: 0.64x
- • Equity Multiplier: 2.36x
- Recent ROE (1.04%) is below the historical average (3.81%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2004 | -34.14% | -10.93% | 1.19x | 2.62x | €-751.20 Million |
| 2005 | -29.54% | -7.76% | 1.18x | 3.22x | €-572.90 Million |
| 2006 | 2.44% | 0.83% | 1.25x | 2.36x | €-145.30 Million |
| 2007 | 6.48% | 2.19% | 1.28x | 2.32x | €-67.40 Million |
| 2008 | 5.01% | 1.78% | 1.26x | 2.24x | €-99.60 Million |
| 2009 | -9.60% | -3.87% | 1.13x | 2.20x | €-351.10 Million |
| 2010 | 15.64% | 5.88% | 1.23x | 2.17x | €125.10 Million |
| 2011 | -0.87% | -0.32% | 1.11x | 2.43x | €-238.00 Million |
| 2012 | 9.64% | 3.44% | 1.15x | 2.43x | €-8.20 Million |
| 2013 | 7.27% | 2.76% | 1.11x | 2.37x | €-63.20 Million |
| 2014 | 4.73% | 2.81% | 0.87x | 1.93x | €-185.90 Million |
| 2015 | 7.31% | 3.71% | 0.88x | 2.24x | €-105.00 Million |
| 2016 | 10.16% | 5.67% | 0.83x | 2.15x | €6.60 Million |
| 2017 | 12.99% | 6.92% | 0.87x | 2.16x | €132.70 Million |
| 2018 | 14.20% | 8.02% | 0.87x | 2.03x | €209.10 Million |
| 2019 | 10.30% | 6.21% | 0.80x | 2.08x | €15.70 Million |
| 2020 | 6.40% | 4.21% | 0.74x | 2.06x | €-186.70 Million |
| 2021 | 20.77% | 13.75% | 0.77x | 1.95x | €678.70 Million |
| 2022 | 13.22% | 8.35% | 0.85x | 1.85x | €235.00 Million |
| 2023 | 5.58% | 4.23% | 0.66x | 2.02x | €-318.30 Million |
| 2024 | 4.70% | 3.71% | 0.63x | 2.02x | €-398.60 Million |
| 2025 | 1.04% | 0.69% | 0.64x | 2.36x | €-541.30 Million |
Industry Comparison
This section compares Arkema SA's net assets metrics with peer companies in the Specialty Chemicals industry.
Industry Context
- Industry: Specialty Chemicals
- Average net assets among peers: $656,606,764
- Average return on equity (ROE) among peers: -30.27%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Arkema SA (AKE) | €6.34 Billion | -34.14% | 1.24x | $4.93 Billion |
| Air Liquide SA (AI) | $5.72 Billion | 14.77% | 1.52x | $101.06 Billion |
| Afyren SAS (ALAFY) | $52.70 Million | -18.51% | 0.11x | $102.91 Million |
| Carbios (ALCRB) | $2.59 Million | -61.91% | 0.55x | $120.91 Million |
| Encres Dubuit SA (ALDUB) | $20.69 Million | 6.37% | 0.27x | $7.39 Million |
| Glob Bioenergi (ALGBE) | $-296.00K | 0.00% | 0.00x | $335.38K |
| Vinpai SAS (ALVIN) | $1.09 Million | -147.24% | 7.01x | $15.94 Million |
| EPC Groupe (EXPL) | $105.53 Million | 1.25% | 1.75x | $597.32 Million |
| Lhyfe SA (LHYFE) | $2.48 Million | -64.50% | 2.93x | $106.24 Million |
| Parx Plastics NV (MLPRX) | $9.58 Million | -2.64% | 0.06x | $4.69 Million |
About Arkema SA
Arkema S.A., together with its subsidiaries, manufactures and sells specialty materials in Europe, the United States, Canada, Mexico, China, Hong Kong, Taiwan, and internationally. It operates in three segments: Adhesive Solutions, Advanced Materials and Coating Solutions, and Intermediates. The company provides solutions for construction, renovation of buildings, and DIY; high performance adhesi… Read more